Clinical Trial Update: A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating Norfloxacin for hepatopulmonary syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatopulmonary Syndrome

Drugs mentioned

• Norfloxacin (Norfloxacin)

Snippet

Sponsor: Unity Health Toronto | Conditions: Hepatopulmonary Syndrome | Phase 2 | Status: COMPLETED